000			01811 a2200517 4500
005			20250513111758.0
264		0	_c19970228
008			199702s 0 0 eng d
022			_a0902-4441
024	7		_a10.1111/j.1600-0609.1997.tb01403.x _2doi
040			_aNLM _beng _cNLM
100	1		_aOsterborg, A
245	0	0	_aClonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52). _h[electronic resource]
260			_bEuropean journal of haematology _cJan 1997
300			_a5-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlemtuzumab
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibodies, Neoplasm _xtherapeutic use
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, Neoplasm
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCD52 Antigen
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aFemale
650	0	4	_aGlycoproteins
650	0	4	_aHumans
650	0	4	_aImmunity, Cellular _xdrug effects
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aT-Lymphocyte Subsets _ximmunology
700	1		_aWerner, A
700	1		_aHalapi, E
700	1		_aLundin, J
700	1		_aHarmenberg, U
700	1		_aWigzell, H
700	1		_aMellstedt, H
773	0		_tEuropean journal of haematology _gvol. 58 _gno. 1 _gp. 5-13
856	4	0	_uhttps://doi.org/10.1111/j.1600-0609.1997.tb01403.x _zAvailable from publisher's website
999			_c9010606 _d9010606